Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
J Histochem Cytochem. 2009 Jan;57(1):7-8. doi: 10.1369/jhc.2008.952820. Epub 2008 Oct 14.

Commercial antibodies: the good, bad, and really ugly.

Author information

  • Biomedicine Institute, University of Copenhagen, Biocenter, Ole Maaloes Vej 5, 2200 Copenhagen N, Denmark. john.couchman@bric.dk

Abstract

The range of antibodies available commercially grows ever larger. Perhaps as a consequence, quality control is not always what it could and should be. Investigators must be aware of potential pitfalls and take steps to assure themselves that the specificity of each antibody is as advertised. Additionally, companies should provide the necessary information about the antigen and antibody to investigators, including references, so that the appropriate controls can be included.

PMID:
18854593
[PubMed - indexed for MEDLINE]
PMCID:
PMC2605718
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk